KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Invested Capital: 2009-2024

Historic Invested Capital for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $1.4 billion.

  • Pacira BioSciences' Invested Capital fell 17.43% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 17.43%. This contributed to the annual value of $1.4 billion for FY2024, which is 2.08% down from last year.
  • Latest data reveals that Pacira BioSciences reported Invested Capital of $1.4 billion as of FY2024, which was down 2.08% from $1.4 billion recorded in FY2023.
  • Pacira BioSciences' 5-year Invested Capital high stood at $1.8 billion for FY2021, and its period low was $1.1 billion during FY2020.
  • Its 3-year average for Invested Capital is $1.4 billion, with a median of $1.4 billion in 2023.
  • In the last 5 years, Pacira BioSciences' Invested Capital surged by 204.94% in 2020 and then decreased by 17.71% in 2022.
  • Over the past 5 years, Pacira BioSciences' Invested Capital (Yearly) stood at $1.1 billion in 2020, then surged by 64.42% to $1.8 billion in 2021, then declined by 17.71% to $1.5 billion in 2022, then declined by 4.91% to $1.4 billion in 2023, then dropped by 2.08% to $1.4 billion in 2024.